The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Manne, J.
Right arrow Articles by Berd, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manne, J.
Right arrow Articles by Berd, D.
The Journal of Immunology, 2002, 169: 3407-3412.
Copyright © 2002 by The American Association of Immunologists

TCR Rearrangement in Lymphocytes Infiltrating Melanoma Metastases After Administration of Autologous Dinitrophenyl-Modified Vaccine1

Jayanthi Manne, Michael J. Mastrangelo, Takami Sato and David Berd2

Department of Medicine, Division of Medical Oncology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107

Administration of a vaccine consisting of autologous melanoma cells modified with a hapten, dinitrophenyl (DNP), induces T cell infiltration of metastatic sites. We have reported an analysis of these infiltrating T cells, indicating that certain TCR-V{beta} gene segments are greatly overexpressed. In this study, we investigate the rearrangement of the TCR-V{beta} as well as the junctional diversity in T cells infiltrating melanoma metastases following treatment with DNP vaccine. In 19 of 26 control specimens, V-D-J length analysis showed the expected polyclonal patterns. In contrast, postvaccine tumors from 9 of 10 patients showed dominant peaks of V-D-J junction size in one or more V{beta} families. Dominant peaks were seen most frequently in six V{beta} families (V{beta}7, 12, 13, 14, 16, and 23) and were never seen in seven others. Further analysis of the oligoclonal V{beta} products showed dominant peaks in the J region as well. Of particular interest was the finding that V{beta} and J{beta} peaks were similar in inflamed metastases obtained at different times or from different sites from the same patient. Although 6 of 10 patients expressed HLA-A1, there was no common pattern of TCR rearrangements among them. Finally, the amplified PCR products from seven of these specimens were cloned and sequenced and the amino acid sequence of the complementarity-determining region 3 was deduced. In six of seven specimens, the same complementarity-determining region 3 sequence was repeated in at least two clones and in five of seven in at least three clones. Our study indicates that DNP vaccine induces the expansion of particular T cell clones that may be agents of its antitumor effects.




This article has been cited by other articles:


Home page
J. Immunol.Home page
J. Zhou, M. E. Dudley, S. A. Rosenberg, and P. F. Robbins
Selective Growth, In Vitro and In Vivo, of Individual T Cell Clones from Tumor-Infiltrating Lymphocytes Obtained from Patients with Melanoma
J. Immunol., December 15, 2004; 173(12): 7622 - 7629.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Willhauck, C. Scheibenbogen, M. Pawlita, T. Mohler, E. Thiel, and U. Keilholz
Restricted T-Cell Receptor Repertoire in Melanoma Metastases Regressing after Cytokine Therapy
Cancer Res., July 1, 2003; 63(13): 3483 - 3485.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.